Phosphodiesterases in heart and vessels-From Physiology to Diseases

Q Fu, Y Wang, C Yan, YK Xiang - Physiological Reviews, 2023 - journals.physiology.org
Phosphodiesterases (PDEs) are a superfamily of enzymes that hydrolyze cyclic nucleotides,
including cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate …

Loss of transforming growth factor beta signaling in aortic smooth muscle cells causes endothelial dysfunction and aortic hypercontractility

J Zhu, S Angelov, I Alp Yildirim, H Wei… - … , and vascular biology, 2021 - Am Heart Assoc
Objective: Humans and mice with loss-of-function variants of genes in the TGF-β
(transforming growth factor beta) signaling pathway develop aortic aneurysms. These …

Development and Application of an Optogenetic Manipulation System to Suppress Actomyosin Activity in Ciona Epidermis

J Qiao, H Peng, B Dong - International Journal of Molecular Sciences, 2023 - mdpi.com
Studying the generation of biomechanical force and how this force drives cell and tissue
morphogenesis is challenging for understanding the mechanical mechanisms underlying …

Myosin light chain phosphatase catalytic subunit dephosphorylates cardiac myosin via mechanisms dependent and independent of the MYPT regulatory subunits

E Lee, Z Liu, N Nguyen, AC Nairn, AN Chang - Journal of Biological …, 2022 - ASBMB
Cardiac muscle myosin regulatory light chain (RLC) is constitutively phosphorylated at∼ 0.4
mol phosphate/mol RLC in normal hearts, and phosphorylation is maintained by balanced …

Complex functionality of protein phosphatase 1 isoforms in the heart

R Liu - Cellular Signalling, 2021 - Elsevier
Abstract Protein phosphatase 1 (PP1) is a key regulator of cardiac function through
dephosphorylating serine/threonine residues within target proteins to oppose the function of …

The MYPT2-regulated striated muscle-specific myosin light chain phosphatase limits cardiac myosin phosphorylation in vivo

E Lee, H May, K Kazmierczak, J Liang… - Journal of Biological …, 2024 - ASBMB
The physiological importance of cardiac myosin regulatory light chain (RLC)
phosphorylation by its dedicated cardiac myosin light chain kinase has been established in …

Tissue-specific expression of myosin phosphatase subunits and isoforms in smooth muscle of mice and humans

K Oslin, JJ Reho, Y Lu, S Khanal… - American Journal …, 2022 - journals.physiology.org
Alternative splicing of exon24 (E24) of myosin phosphatase targeting subunit 1 (Mypt1) by
setting sensitivity to nitric oxide (NO)/cGMP-mediated relaxation is a key determinant of …

Characterisation of P2 receptors that modulate vascular tone in pulmonary arteries

MO Dales - 2022 - stax.strath.ac.uk
Purinergic P2Y receptors are a family of eight G protein-coupled receptors (P2Y1, 2, 4, 6, 11,
12, 13, 14) that are activated by nucleotides to elicit both vasoconstriction and vasodilation …

The uterine myocyte, contractile machinery and proteins of the myometrium and their relationship to the dynamic nature of myometrial function

LP Kajuluri, Y Li, KG Morgan - Current Opinion in Physiology, 2020 - Elsevier
The molecular mechanisms of regulation of myometrial contractility, and, hence, the
mechanisms of regulation of the onset of labor and delivery during pregnancy have been an …

Exploring Myosin RLC Phosphorylation as a Potential Novel Therapeutic Target for Hypertrophic Cardiomyopathy

S Yadav - 2019 - search.proquest.com
Background: Hypertrophic Cardiomyopathy (HCM) is one of the most prevalent heart
diseases characterized by ventricular and septal hypertrophy, myocardial fibrosis and …